Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CGG Repeat Expansion in LRP12 Causes Inherited Peripheral Neuropathy
General Neurology
S3 - General Neurology 1 (2:00 PM-2:12 PM)
006

Recently, CGG repeat expansions in LRP12, GIPC1, and RILPL1 genes have been found to be associated with oculopharyngodistal myopathy (OPDM), which provides insight into various undiagnosed neurodegenerative disorders. 

This study aimed to identify the role of these CGG repeat expansions in Japanese patients with inherited peripheral neuropathy (IPN)

We collected DNA samples from 2,424 unrelated Japanese patients with IPN and selected 1,555 unidentified cases after conducting a series of prescreening analyses. Together with eight patients diagnosed with OPDM, we screened for CGG repeat expansions in LRP12GIPC1, and RILPL1 genes using repeat-primed polymerase chain reaction (PCR), fluorescence amplicon length analysis-PCR, and long-read sequencing technologies. We summarized the clinical, electrophysiological, radiological, and pathological features of patients with disease-causing CGG repeat expansions.

Within the IPN group, LRP12 CGG repeat expansions were identified in 44 cases (LRP12-IPN), which was the fourth most common etiology in this case series. Most cases (29/37) developed only distal limb weakness without ptosis, ophthalmoplegia, facial muscle weakness, or bulbar palsy. Neurogenic changes were commonly observed using needle electromyography (97%) and skeletal muscle biopsy (100%). The number of LRP12 CGG repeat extensions of LRP12-IPN was less than that of three LRP12-OPDM patients (76.41 ± 17.97 vs. 127.00 ± 22.87 ; = 0.0013). Additionally, we observed selective atrophy in lower limb flexor muscles and p62-positive inclusions in skeletal muscle and peripheral nerve samples regardless of the clinical phenotype. No CGG repeat expansion was detected in GIPC1 and RILPL1.

We proposed LRP12-IPN as a novel disease entity associated with shorter CGG repeats than the typical LRP12-OPDM phenotype. As the proportion of LRP12-IPN was high among patients with IPN, we strongly recommend the genetic screening of CGG repeats in LRP12, especially in undiagnosed cases.
Authors/Disclosures
Takahiro Hobara (Kagoshima University Graduate School of Medical and Dental Sciences)
PRESENTER
Dr. Hobara has nothing to disclose.
Masahiro Ando No disclosure on file
Yujiro Higuchi No disclosure on file
Akiko Yoshimura No disclosure on file
Jun-Hui Yuan No disclosure on file
Fumikazu Kojima No disclosure on file
Yutaka Noguchi No disclosure on file
Akihiro Hashiguchi No disclosure on file
Eiji Matsuura, MD (Kagoshima University) Dr. Matsuura has nothing to disclose.
Hiroshi Takashima, MD, PhD (Neurology, Kagoshima University) Dr. Takashima has nothing to disclose.